Reference Standards, Certified Reference Materials and the Quantification Baseline

A certified reference material (CRM) is defined under ISO Guide 30:2015 as a reference material characterised by a metrologically valid procedure for one or more specified properties, accompanied by a certificate that provides the value of the specified property, its associated uncertainty, and a statement of metrological traceability. Unpacking this definition reveals what a CRM actually is.

The "metrologically valid procedure" means the purity or concentration has been determined using analytical methods whose accuracy has been verified against primary references, not merely by comparison to another commercially purchased material. Primary purity determination for an organic compound typically involves quantitative NMR (qNMR), differential scanning calorimetry (DSC), and independent chromatographic methods (HPLC, GC), with the results combined using a mass-balance approach to arrive at a certified purity.

"Metrological traceability" means there is an unbroken chain of calibrations, each with a stated uncertainty, linking the CRM's certified value to a primary standard, ultimately to the International System of Units (SI). For a drug reference standard certified at, for example, 99.6 per cent purity (±0.3 per cent at k=2, 95 per cent confidence), the traceability chain typically runs: the primary measurement at the national metrology institute (NIST in the US, PTB in Germany, NPL in the UK, NMIJ in Japan, CSIR-NPL in India) using primary reference methods, through calibration of the characterisation instruments against SI-traceable standards, to the CRM certificate issued to the end user. When the forensic chemist uses that CRM to calibrate an instrument and derive a concentration for a case sample, the traceability of the case result to SI is established through this chain.

The "certificate" is the key document. It must state: the certified property (purity, concentration), the certified value and its expanded uncertainty (with coverage factor and confidence level), the characterisation methods used, the storage conditions, the expiry date or expiry criteria, and the name of the issuing body. A bottle of a chemical compound with only an "Assay by HPLC: NLT 98.0%" specification on the label is not a CRM; it is a chemical-grade reagent. The difference matters enormously in court. The ISO 17025 and NABL quality systems for forensic chemistry laboratories topic explains how accreditation bodies audit CRM traceability records during laboratory assessments.

In forensic chemistry, CRMs are used in two ways. For identification, the CRM's spectral data (GC-MS mass spectrum, FTIR spectrum, NMR spectrum) serves as the reference against which the case sample's spectrum is compared. For quantification, the CRM is used to prepare calibration standards at known concentrations, and the instrument response to those standards is used to derive a calibration curve from which case sample concentrations are calculated. How CRM-calibrated GC-MS and LC-MS/MS slot into the full drug identification decision tree is covered in SWGDRUG Identification Tiers and the UV-TLC-GC-MS-LC-MS/MS Workflow.

The forensic chemist works with CRMs from a small number of authoritative sources whose certification processes are ISO 17034-accredited or otherwise internationally recognised. Understanding the major suppliers and their scope is essential for ordering correctly, using appropriately, and defending the choice in court.

United States Pharmacopeia (USP) Reference Standards. The USP issues reference standards for pharmaceutical compounds, including many controlled substances that are also forensic targets. USP reference standards are characterised to pharmacopeial-grade purity using multiple orthogonal methods; they are accompanied by a certificate of analysis stating the assigned content (purity), the characterisation methods, and the lot-specific expiry. USP reference standards for controlled substances (including morphine, codeine, cocaine, amphetamine, methamphetamine, MDMA, fentanyl, diazepam, and dozens of others) are widely used in US forensic drug laboratories and internationally. The USP is not a national metrology institute, but its standards are accepted as authoritative in US federal courts and by SWGDRUG as appropriate sources for forensic drug analysis. DEA laboratories use USP reference standards for routine drug identification and quantification.

NIST Standard Reference Materials (SRM). The National Institute of Standards and Technology (NIST) in Gaithersburg, Maryland, issues SRMs, the US primary reference materials whose values are SI-traceable through NIST's own primary measurement capability. NIST SRMs relevant to forensic chemistry include alcohol standards (SRM 1828 for forensic blood-alcohol determination), drug standards (SRM 2382 for marijuana, SRM 1957 for organic contaminants in non-fortified human serum), and inorganic standards for elemental analysis. NIST SRMs carry the highest metrological pedigree in the US system and are used as primary calibrators in high-stakes forensic cases. For a methamphetamine quantification where the case may go to a federal trial, a NIST-traceable calibration chain (either through a NIST SRM directly or through a secondary CRM whose characterisation is traceable to NIST) provides the strongest defence against a challenge to the measurement's accuracy.

BAM (Federal Institute for Materials Research and Testing, Germany). The BAM is Germany's national metrology institute for materials and operates an accredited reference materials producer (BAM-RM) under ISO 17034. BAM produces CRMs for explosives (trinitrotoluene, RDX, PETN, HMX, TATP, ANFO components), forensic drugs, and environmental contaminants. These BAM explosive CRMs are the quantification anchors for post-blast residue analysis by IMS, GC-ECD and LC-MS/MS. BAM CRMs are widely used across EU member state forensic laboratories and by ENFSI DWG member labs for drug profiling and quantification. The BAM CRM catalogue for explosives analysis is among the most comprehensive available globally and is particularly relevant for post-blast residue quantification.

NMIJ (National Metrology Institute of Japan). NMIJ in Tsukuba issues certified reference materials for drugs, pesticides, environmental contaminants, and industrial chemicals, with SI-traceable certificates. NMIJ CRMs for organic compounds including controlled substances are used in Japan, across the Asia-Pacific region, and increasingly in India (where CSIR-NPL in New Delhi is the primary national metrology institute but collaborates with NMIJ for organic compound standards). CFSL laboratories have access to NMIJ standards through the CSIR-NPL procurement framework and through commercial distributors.

Cerilliant Corporation (a Sigma-Aldrich/MilliporeSigma brand, US). Cerilliant is not a national metrology institute but is a DEA Schedule I/II/III-licensed manufacturer of certified reference standards for controlled substances and their metabolites. Cerilliant standards are certified using multiple characterisation methods and are SI-traceable through USP or NIST primary standards. They are the most widely used CRM source for forensic drug laboratories in the US, Canada, and internationally, covering an exceptionally broad range of controlled substances, metabolites, novel psychoactive substances, and veterinary drugs (including xylazine, which has emerged as a critical fentanyl adulterant). DEA laboratories and state crime laboratories routinely use Cerilliant standards for both identification reference spectra and quantification calibrations.

Sigma-Aldrich / LGC Standards / Cayman Chemical. Several other commercial suppliers produce reference standards of varying quality. LGC Standards (UK) produces certified reference materials under ISO 17034 accreditation from UKAS; these are widely used in UK forensic laboratories. Cayman Chemical (US) produces research-grade reference standards for many NPS and cannabinoids, but not all products are certified to ISO 17034; the forensic chemist must check the certificate type before using a Cayman product as a forensic CRM.

The critical question for any reference material used in forensic chemistry is: is there a certificate with a stated uncertainty, stated characterisation methods, stated traceability, and an expiry date? If any of these elements is missing, the material does not meet the definition of a CRM under ISO Guide 30 and its use in a quantification that will be reported in court is scientifically unjustifiable.

ISO/IEC 17034:2016 (General requirements for the competence of reference material producers) specifies what an organisation must do to be recognised as a competent producer of certified reference materials. It is distinct from ISO/IEC 17025:2017 (which covers testing and calibration laboratories) and ISO 9001 (quality management systems). A laboratory that is ISO 17025-accredited is competent to test samples and issue test reports; a producer that is ISO 17034-accredited is competent to characterise and certify reference materials.

The key requirements under ISO 17034 that matter for forensic chemistry users:

Homogeneity and stability studies. The producer must demonstrate that the CRM is homogeneous (so that any portion of the material has the same property value) and stable (so that the certified value does not change during the stated validity period under specified storage conditions). For a controlled substance reference standard in solution (e.g. 1 mg/mL cocaine in methanol), stability under refrigerated storage must be demonstrated over the stated shelf life. If the bottle has been improperly stored (left at room temperature for an extended period, repeatedly freeze-thawed), the certified value is no longer assured, even if the expiry date has not passed.

Characterisation uncertainty. The producer must use at minimum two independent analytical methods to characterise the property value, and must calculate a combined uncertainty that accounts for measurement uncertainty from each method, homogeneity uncertainty, and stability uncertainty. The expanded uncertainty (typically at k=2, 95 per cent confidence) is the number reported on the certificate. When the forensic chemist uses the CRM in a calibration, this characterisation uncertainty is propagated through the calibration and contributes to the total measurement uncertainty of the case result.

Traceability statement. The certificate must state the traceability chain: typically, "traceable to SI through [primary standard or NMI]." For organic compound CRMs, this is typically established through traceability to the International System of Units via molar mass (atomic weights from IUPAC) and primary measurement methods (qNMR with chemical-shift reference standards traceable to SI, or coulometry) at the NMI level.

Accreditation body recognition. In the US, CRM producers are accredited by A2LA or NVLAP under ISO 17034. In the UK, by UKAS. In Germany, by DAkkS. In Japan, by IAJapan. In India, NABL (National Accreditation Board for Testing and Calibration Laboratories) accredits both ISO 17025 laboratories and, since 2019, ISO 17034-compliant reference material producers. A CRM producer with ISO 17034 accreditation from a recognised accreditation body in the ILAC Mutual Recognition Arrangement (MRA) is internationally accepted; one without such accreditation is not.

The practical implication: when a forensic laboratory purchases a drug reference standard, the accreditation of the producer under ISO 17034 (or the direct linkage to a national metrology institute) determines whether the material's certified values are defensible in court. Many commercially available "purity standards" or "analytical standards" are not produced under ISO 17034; their manufacturers make no warranty of metrological traceability, and their use in court-level quantification is scientifically and legally unjustifiable.

Method validation (the process by which an analytical laboratory demonstrates that a method performs as intended for its intended use) generates a set of performance parameters that define the method's scope and limitations. Four parameters are most critical in forensic chemistry quantification: limit of detection (LOD), limit of quantification (LOQ), linearity, and recovery.

Limit of Detection (LOD). The LOD is the smallest concentration of the analyte that can be detected with reasonable statistical certainty, but not necessarily quantified. Operationally, it is typically defined as the concentration corresponding to a signal-to-noise ratio of 3:1 in the analytical method. Below the LOD, the method cannot reliably distinguish the analyte's signal from the baseline noise. In drug analysis, the LOD is important for trace-level samples (residues on packaging, drug residues in biological matrices at very low concentrations). A result reported as "detected" but below the LOD has no quantitative validity and should be reported as "trace detected, below quantification threshold."

In forensic chemistry reports in India, the FSL reporting convention has historically often been binary (present/absent), but the CFSL's more rigorous practice for drug quantification uses the LOD as the lower boundary below which no quantitative claim is made. In US DEA laboratories, LOD is established during method validation per SWGDRUG guidelines and must be reported in the method validation documentation that accompanies the SOP. Under ISO 17025, any accredited laboratory must have an established LOD for each quantitative method it offers.

Limit of Quantification (LOQ). The LOQ is the smallest concentration that can be quantified with a stated precision and accuracy. It is typically defined as the concentration corresponding to a signal-to-noise ratio of 10:1, or by the concentration at which the relative standard deviation (RSD) of repeated measurements falls below an acceptable threshold (typically 20 per cent for biological matrices per FDA bioanalytical guidance, or lower for drug chemistry). Below the LOQ, a signal may be present (i.e., above the LOD) but its quantification is too imprecise to be reportable as a concentration. A result between the LOD and LOQ may be reported as "detected, below quantification limit" or as a semi-quantitative estimate with appropriate caveats. A result above the LOQ is the only category that should appear as a specific concentration in a court report.

Linearity. The linearity of a method describes the range over which the instrument's response (peak area, absorbance, ion count) is proportional to the concentration of the analyte. Most analytical instruments have a linear dynamic range over several orders of magnitude, but the linearity of a specific method (the combination of sample preparation, instrument parameters, and calibration) is more limited. The linearity is established during method validation by preparing calibration standards at a minimum of five concentration levels (including the LOQ and the upper end of the expected concentration range) and fitting a regression model, typically linear (y = mx + b) but sometimes quadratic for methods with known curvature at higher concentrations. The coefficient of determination (r²) should be at least 0.999 for routine forensic drug quantification methods. Any case result that falls outside the validated linear range should be diluted and re-analysed, not extrapolated from the calibration curve beyond its validated bounds.

In US DEA laboratories, the linearity requirement for drug quantification methods specifies a minimum of five calibration levels spanning the expected quantification range, with an r² of at least 0.999. This requirement comes from the DEA Laboratory Operations Manual and from SWGDRUG guidelines. In the UK, the FSR Codes of Practice reference ISO 17025 method validation requirements, which align with the same r² standard.

Recovery. Recovery is the fraction of the analyte present in the original sample that is measured by the analytical method, expressed as a percentage of the true amount. In drug chemistry, recovery measures how efficiently the sample preparation procedure (extraction, dilution, derivatisation) and the instrument system together capture the analyte. A recovery of 85 per cent means that 15 per cent of the analyte is lost during the process; a recovery of 110 per cent (super-recovery) may indicate matrix enhancement effects or calibration issues. Acceptable recovery ranges in forensic drug analysis are typically 80 to 120 per cent (or tighter, 90 to 110 per cent, for high-stakes quantification such as NDPS commercial-quantity determinations).

Recovery is measured during method validation by spiking a blank matrix (a known analyte-free sample of the same type as the case matrix) with a known amount of the CRM analyte, processing it through the full analytical method, and comparing the measured amount to the spiked amount. Recovery must be assessed across the expected concentration range and for each analyte in a multi-component method.

Measurement uncertainty (MU) is a parameter, associated with the result of a measurement, that characterises the dispersion of the values that could reasonably be attributed to the measurand (the quantity being measured). In simpler terms: no measurement is exact, and the MU tells you how far the true value could be from the reported value.

In forensic chemistry, MU is expressed as an expanded uncertainty (U) at a specified confidence level. The convention is U at k=2 (approximately 95 per cent confidence for a normal distribution), meaning there is about a 95 per cent probability that the true value lies within the interval [reported value minus U, reported value plus U]. A heroin purity reported as "62 ± 4 per cent (U at k=2)" means the analyst is stating 95 per cent confidence that the true purity is between 58 per cent and 66 per cent.

The sources of uncertainty in a forensic chemistry quantification include: uncertainty from the CRM certificate (the characterisation uncertainty of the standard); uncertainty from the preparation of calibration standards (pipetting, dilution, weighing); uncertainty from the calibration curve fit (regression uncertainty); uncertainty from the instrument repeatability (within-run variation); uncertainty from the method precision (between-run variation); and uncertainty from recovery (if a correction is not applied). These components are combined using the law of propagation of uncertainty (ISO/IEC Guide 98-3, the Guide to the Expression of Uncertainty in Measurement, the GUM) to give a combined standard uncertainty, which is then multiplied by the coverage factor k to give the expanded uncertainty U.

Why MU matters in court. A purity of 62 ± 4 per cent is not a statement that the analyst is uncertain about the answer. It is a statement that a second analyst using a different calibrated instrument and a different CRM batch would, within normal method variation, also get a result somewhere in that range. When the UK FSR Codes of Practice require MU to be reported, and when SWGDRUG and ISO 17025 both mandate its calculation and disclosure, the purpose is to prevent courts from treating analytical results as more precise than the method actually allows.

The practical significance arises directly when a quantification result is near a legal threshold. In India, if the heroin purity determination is being used to calculate the net pure substance content of a commercial-quantity consignment, an MU of ±4 per cent can be the difference between a finding at 250 g net pure heroin (the commercial-quantity threshold under the NDPS Act) and a finding of 245 g, below the threshold. The full NDPS quantity-band structure and how courts apply it is set out in Controlled Substances Schedules: NDPS, CSA, MDA and EU Framework. Courts in India have addressed this issue through the concept of benefit of the doubt in threshold calculations, but the benefit only applies if the uncertainty is properly calculated and disclosed. An analyst who reports "250 g pure heroin" without any MU statement is not helping the court; they are denying the court information it needs to apply the law correctly.

In Germany, the BGH (Federal Court of Justice) has specifically addressed measurement uncertainty in drug quantity determinations, holding in BGH 4 StR 84/21 (2021) that courts must consider the measurement uncertainty when applying quantity thresholds under the BtMG, and that the quantity used for sentencing should be the lower bound of the confidence interval (reported value minus U) rather than the nominal reported value, giving the accused the benefit of the analytical uncertainty.

In the UK, the MU requirement in FSR Codes is framed as a matter of fitness for purpose: the MU must be small enough relative to the stated purity for the conclusion to be meaningful, and must be reported so the court can assess whether the result is reliable enough to make a threshold determination. The Crown Prosecution Service's guidance on forensic science notes that MU should be explicitly addressed in the expert witness statement.

Calibration discipline in forensic chemistry refers to the set of practices that ensure an instrument's response to known concentrations of the analyte remains stable and predictable over time and across casework batches. Without calibration discipline, a result that was accurate when the method was first validated may drift to inaccuracy as detector sensitivity changes, column efficiency decreases, or instrument components age.

Multi-level calibration. Every quantification run in a forensic chemistry laboratory must include calibration standards at multiple concentration levels spanning the validated linear range. A minimum of five calibration levels is required under SWGDRUG guidelines and recommended under ISO 17025. Each calibration level is prepared from the primary CRM (or from a traceable secondary standard prepared from the CRM). The calibration curve is fitted to the calibration data for that run, and the case sample concentrations are derived from this run-specific curve. Using a calibration curve from a previous run (a practice called "historical calibration") is not acceptable in rigorous forensic practice because it does not account for day-to-day instrument variation.

Internal standards. An internal standard (IS) is a compound added at a known concentration to every calibration standard, quality control standard, and case sample before preparation. The IS should be structurally analogous to the target analyte so that it experiences the same matrix effects, the same extraction recovery, and the same ionisation efficiency variations. The ratio of the analyte signal to the IS signal, rather than the absolute analyte signal, is used for quantification. This ratio-based approach corrects for variations in injection volume, instrument response drift, and matrix-induced signal enhancement or suppression. For GC-MS drug analysis, deuterium-labelled analogues of the target drug (e.g. d3-methamphetamine, d5-cocaine, d9-THC) are the gold standard internal standards because they are chemically and chromatographically almost identical to the native compound but produce a distinct mass spectrum due to the mass shift of the deuterium labels.

Quality control standards. In addition to calibration standards, every analytical run includes quality control (QC) standards at known concentrations: typically a low QC (near the LOQ), a mid QC (in the middle of the linear range), and a high QC (near the upper end of the range). These are prepared independently from the calibration standards (from a separate weighing or dilution series) and processed through the full analytical method. Their measured concentrations are compared to their known concentrations; acceptance criteria (typically ±15 per cent or ±20 per cent of the nominal value, depending on the method) must be met for the run to be valid. A QC failure invalidates the associated analytical run; the case samples must be re-run, not simply reported with the failed QC results disclosed as a caveat.

Instrument qualification. An instrument cannot produce reliable quantification results if it is not operating within its qualified performance parameters. Instrument qualification in a forensic laboratory includes installation qualification (IQ: the instrument is installed correctly), operational qualification (OQ: the instrument performs to its manufacturer's specification under standard conditions), and performance qualification (PQ: the instrument continues to perform within specification during routine operation). PQ is typically assessed daily before any casework run through system suitability tests: injection of a standard mixture and verification that key parameters (retention times, peak widths, signal-to-noise, resolution between co-eluting peaks) fall within defined acceptance limits. A system suitability failure triggers corrective maintenance before the casework run is allowed to proceed.

In India, CFSL instruments are maintained under calibration and maintenance schedules supervised by the Quality Manager (a requirement of the NABL accreditation scope). The instrument calibration records must show that the instrument was within its qualified performance range on the day the case analysis was performed. For the SWGDRUG identification tier framework, CRM-calibrated GC-MS and LC-MS/MS form the Category A backbone that every court-level drug identification depends on. In the US, DEA laboratory instruments are maintained under manufacturer service contracts and internal PQ protocols documented in the laboratory's quality manual. In the UK, FSR-accredited provider laboratories demonstrate instrument qualification as part of their UKAS ISO 17025 accreditation audit.

1. Select the CRM
   Identify the target analyte. Select a CRM from a recognised ISO 17034-accredited producer (USP, NIST, BAM, NMIJ, Cerilliant/LGC). Verify the certificate: purity value, expanded uncertainty, expiry date, traceability statement, characterisation methods. Record the lot number.
2. Prepare calibration standards
   Prepare a series of at minimum five calibration standards at concentrations spanning the validated linear range (from the LOQ to the upper validated limit). Each preparation step (weighing, dilution) is performed gravimetrically (by weight) or volumetrically with calibrated glassware and documented in the analytical record.
3. Add internal standard
   Add the deuterium-labelled or structurally analogous internal standard at a fixed known concentration to every calibration standard, QC standard, and case sample before any extraction or preparation step. Record the IS lot number and concentration.
4. Run system suitability
   Inject the system suitability standard at the start of the run. Verify that retention times, peak symmetry, signal-to-noise, and resolution all meet the acceptance criteria in the method SOP. Proceed only if all criteria pass.
5. Run calibration and QC standards
   Inject calibration standards in concentration order. Fit the calibration curve. Inject QC standards. Verify QC accuracy is within ±15 per cent (or the method-specific criterion) of the nominal value. If any QC fails, troubleshoot and re-run.
6. Run case samples
   Inject case samples using the same validated instrument parameters. Calculate concentrations from the run-specific calibration curve. Report the concentration with the expanded measurement uncertainty propagated from CRM certificate, calibration, and method precision components.
7. Document and archive
   Archive all raw data, calibration curves, QC results, system suitability records, CRM certificates, and analyst notes in the LIMS. This archive must be retained for the minimum period specified by the laboratory's accreditation body and the relevant jurisdiction's evidentiary record-keeping requirements.